Liver Cancer Prevention: Lifestyle & Vaccination
Liver cancer Cases Set to Soar as Obesity Fuels Rise in Fatty Liver Disease
Table of Contents
Global liver cancer cases are projected to increase by over 50% by 2050, driven by a surge in obesity-related fatty liver disease and rising alcohol consumption, according to a new commission report.
London – The global burden of liver cancer is expected to rise dramatically in the coming decades, with projections indicating an increase from 900,000 cases in 2022 to 1.52 million by 2050. This alarming trend is largely attributed to population growth, ageing demographics, and a notable uptick in obesity-related fatty liver disease, with Africa anticipated to bear the brunt of these increases.
The Shifting Landscape of Liver Cancer Causes
Historically, viral hepatitis (Hepatitis B and C) and alcohol have been the primary drivers of liver cancer. However, the report highlights a significant shift, with metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), emerging as one of the fastest-growing causes.”Liver cancer was once thought to occur mainly in patients with viral hepatitis or alcohol-related liver disease,” explained Prof Hashem B El-Serag of Baylor College of Medicine in the US, a lead author of the commission’s findings. “However, today, rising rates of obesity are an increasing risk factor for liver cancer, primarily due to the increase in cases of excess fat around the liver.”
MASLD, characterized by fat buildup in the liver, affects an estimated one-third of the global population. While preventable through a balanced diet, physical activity, and weight management, a subset of individuals with MASLD can develop the more severe form, metabolic dysfunction-associated steatohepatitis (MASH). MASH is a significant precursor to liver cancer, and its associated cases are projected to rise from 8% in 2022 to 11% by 2050.Alcohol consumption remains a critical factor, with liver cancer cases linked to alcohol expected to increase from 19% in 2022 to 21% in 2050. In contrast, the proportion of liver cancer cases attributed to Hepatitis B is forecast to slightly decrease from 39% to 37%, and Hepatitis C-related cases are projected to drop from 29% to 26%.
China’s Hepatitis B Challenge
Currently, China accounts for over 40% of global liver cancer cases, a statistic largely driven by its high rates of Hepatitis B infections.
Urgent Need for Prevention and Early Detection
The commission’s report underscores the urgent need for thorough public health strategies to combat this growing crisis. key recommendations include:
Boosting Hepatitis B Vaccination: Governments are urged to enhance HBV vaccination programs and implement universal screening for adults to curb the spread of the virus.
Alcohol and Sugar Control: Measures such as minimum alcohol unit pricing, sugar taxes, and clear warning labels on alcoholic beverages are proposed to reduce alcohol-related liver damage. Investing in Early detection: Increased investment in early detection methods for liver damage and cancer is crucial to improve patient outcomes.
Improving Palliative Care: Enhancing palliative care services for individuals diagnosed with liver cancer is essential to improve their quality of life.
Prof Valérie Paradis of Beaujon hospital in France, another author of the commission, emphasized the importance of societal awareness. “There is an urgent need to raise awareness within society about the severity of the growing health issue of rising liver cancer cases,” she stated. “Compared with other cancers, liver cancer is very hard to treat but has more distinct risk factors, which help define specific prevention strategies. With joint and continuous efforts, we believe many liver cancer cases can be prevented, and both the survival and quality of patients with liver cancer will be considerably improved.”
Dr Matt Hoare, an associate professor in hepatology at the University of Cambridge’s Early Cancer Institute, noted that liver cancer is unusual in that its death rate is still rising, with regional variations in causes. He pointed to Japan’s success in reducing its death rate through preventive policies and improved early detection as a model for other nations. His team is actively exploring new methods, such as DNA sequencing of the liver, to identify patients at high risk of developing liver cancer.